Technology

Itamar Medica

$24.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.70 (-2.75%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Itamar Medica and other stocks, options, and ETFs commission-free!

About ITMR

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel. The listed name for ITMR is Itamar Medical Ltd. American Depository Shares.

CEO
Gilad Glick
Employees
184,000
Headquarters
Caesarea, Haifa
Founded
1997
Market Cap
358.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
47.95K
High Today
$25.32
Low Today
$24.35
Open Price
$24.85
Volume
24.30K
52 Week High
$29.00
52 Week Low
$7.82

Collections

ITMR Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 2, Pre-Market

You May Also Like

NUMG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure